Ancient Denisovan DNA Still Active in Modern Humans, Study Finds

Ancient DNA is not idle—it is still flipping genetic switches inside our cells
Yale researchers found that inherited Denisovan DNA actively regulates genes affecting immunity and bone development in modern South Pacific populations.

Tens of thousands of years after the Denisovans vanished from the earth, their genetic legacy persists not as a dormant relic but as living machinery still shaping how human bodies fight disease and build bone. Researchers at Yale University have found that over 3,100 fragments of inherited Denisovan DNA remain functionally active in South Pacific populations, switching genes on and off in ways that trace back to ancient encounters between migrating humans and a species known only from a handful of cave fossils. This discovery asks us to reconsider what inheritance truly means — not merely a record of who came before, but an ongoing conversation between the deep past and the living present, one with real consequences for medicine and for the communities long left out of it.

  • Ancient DNA once dismissed as genetic background noise is actively regulating immunity and skeletal development in living people today, upending assumptions about what inherited fragments actually do.
  • South Pacific islanders carry traces of at least three distinct Denisovan groups — evidence of repeated intermingling 45,000 years ago that gave early settlers a survival edge against pathogens their immune systems had never encountered.
  • Yale researchers moved beyond mapping ancient DNA to testing it, inserting thousands of Denisovan fragments into living cells and watching more than 3,100 of them alter gene expression like dimmer switches still wired to the grid.
  • The same skeletal gene shaped by Denisovan inheritance appears under natural selection in rainforest communities in Africa and mountain communities in Ecuador — suggesting evolution independently discovered the same solution across three distant corners of the world.
  • Because genomic databases have long skewed toward European populations, the functional ancient DNA found in South Pacific communities has gone unstudied, threatening to deepen health inequalities as medicine grows more genetically personalized.
  • The team's findings make a direct case for including underrepresented populations in genomic research — not as an act of inclusion for its own sake, but because their DNA is actively relevant to understanding human health and disease.

For years, the Neanderthal DNA carried by modern humans has been treated as little more than a genetic curiosity — a souvenir from a distant past. A Yale University research team led by anthropologist Serena Tucci has now shown that the ancient DNA we inherited is anything but inert. In South Pacific populations, fragments of Denisovan DNA are still actively switching genes on and off, with measurable effects on immune function and bone development.

Tucci's team sequenced the complete genomes of 177 people across a dozen communities in Near Oceania — Papua New Guinea and surrounding islands — and compared them against roughly 1,300 people worldwide. The region had been almost entirely absent from the large genetic databases that have historically favored people of European descent, a gap Tucci recognized as a growing threat to equitable medicine. What the sequencing revealed was a far more layered ancestry than expected: the ancestors of these communities arrived at least 45,000 years ago and mixed with Denisovans not once, but repeatedly, with at least three distinct Denisovan-related groups.

Previous research could locate ancient DNA in modern genomes but could only guess at its function. Tucci's team went further, inserting thousands of Denisovan fragments into living cells and observing the results directly. More than 3,100 of those fragments actively altered how nearby genes were expressed — functional machinery still running after tens of thousands of years. The ancient DNA clustered heavily around immune system pathways, suggesting it helped early islanders defend against unfamiliar pathogens when they first arrived. It also shaped genes involved in skeletal development, and strikingly, the same gene appears under natural selection in rainforest communities in central Africa and highland communities in Ecuador — three distant populations apparently converging on the same evolutionary solution.

The implications reach beyond evolutionary biology. Researchers have already linked a stretch of Neanderthal DNA to severe COVID-19 risk, hinting at the medical relevance of ancient inheritance. By demonstrating that Denisovan DNA in South Pacific populations is functionally active and medically significant, Tucci's team has made a pointed argument: as genetic medicine advances, the communities long excluded from genomic research cannot afford to remain on the margins. The Denisovans are gone, but what they passed on is still at work.

For years, the discovery that modern humans carry fragments of Neanderthal DNA has been treated as a curiosity—a genetic souvenir, almost, something to mention at dinner parties and then move on. But a team of researchers at Yale University has found that the ancient DNA we inherited is far from inert. It is still working, still switching genes on and off inside our cells right now, with measurable consequences for how our bodies fight disease and build bone.

Serena Tucci, an assistant professor of anthropology at Yale, led the effort to understand this active inheritance. For decades, the massive databases that catalog human genetic variation have been skewed heavily toward people of European descent, leaving vast regions of the world—particularly the South Pacific—almost entirely unmapped. Tucci recognized that this gap could widen health inequalities as medicine becomes increasingly tailored to genetic profiles. Her team sequenced the complete genomes of 177 people across a dozen communities in Near Oceania, the southwestern Pacific region spanning Papua New Guinea and surrounding islands, and compared those results against roughly 1,300 people worldwide.

What emerged was a far more complex family history than anyone had suspected. The ancestors of these island communities arrived at least 45,000 years ago and encountered an extinct human species called the Denisovans, known to science only from a handful of fossil fragments discovered in a Siberian cave. The genetic record revealed something unexpected: these early settlers did not mix with Denisovans once, but repeatedly, with at least three distinct Denisovan-related groups. The islands became a meeting place between human populations separated by tens of thousands of years of evolution.

But locating ancient DNA in modern genomes is only the first step. Previous research could identify where these fragments sat in our DNA and make educated guesses about what they might do. Tucci's team went further. They took thousands of these inherited pieces of Denisovan DNA and inserted them into living cells, then observed what happened. The results were striking: more than 3,100 of these ancient fragments actively changed how nearby genes were expressed, turning them up or down like dimmer switches on a light. This was not background noise. This was functional machinery, still running after tens of thousands of years.

The pattern of where this active DNA clustered revealed something even more telling. A disproportionate share of it gathered in the immune system, particularly around the mechanisms cells use to detect and fight off viruses and bacteria. When ancient settlers arrived on these islands, they encountered pathogens their bodies had never encountered before. The Denisovan DNA they carried appears to have strengthened their defenses against these unfamiliar threats. Patrick Reilly, the study's first author, noted that infection has always been one of evolution's harshest filters, eliminating those who could not mount an effective immune response. The genetic inheritance from Denisovans gave early islanders an advantage in that brutal competition.

The ancient DNA also influenced how the body builds bone, affecting genes involved in skeletal development. What makes this finding remarkable is that the same gene shows strong signs of natural selection in rainforest hunter-gatherer communities in central Africa and in mountain communities high in Ecuador. Three distant corners of the world, separated by thousands of miles and thousands of years, appear to have relied on the same genetic solution to adapt to their environments. Evolution, it seems, sometimes discovers the same answer independently.

These findings have immediate practical implications. Researchers have already identified a stretch of Neanderthal DNA linked to increased risk of severe COVID-19, suggesting that understanding our ancient inheritance could improve medical treatment. But the broader significance lies in what this work means for populations long excluded from genetic research. As medicine becomes increasingly personalized and genetic, the underrepresentation of non-European populations in genomic databases threatens to widen existing health disparities. By studying communities in the South Pacific and demonstrating that their ancient DNA is functionally active and medically relevant, Tucci's team has made a case for why these populations must be included in the genetic research that will shape medicine for decades to come. The Denisovans disappeared thousands of years ago, but their genetic legacy continues to shape human health in the present day.

Genes inherited from Denisovans bolstered immunity to viruses and bacteria, helping early islanders survive in an environment filled with unfamiliar pathogens.
— Patrick Reilly, first author of the study
A Conversa do Hearth Outra perspectiva sobre a história
Inventor

Why does it matter that this DNA is active rather than just sitting there?

Model

Because active DNA is doing something. It's not a fossil. It's regulating genes right now, in living people. If it's affecting immunity or bone development, then understanding it could help us predict disease risk or treat conditions more effectively in these populations.

Inventor

But these are small fragments, right? How much of a difference can they really make?

Model

Small in size, but not in number or scope. Over 3,100 fragments are actively working. And they're concentrated in the immune system, which is one of the most important systems in the body. When you're facing a new pathogen, even a small genetic advantage can mean survival.

Inventor

The study mentions three different Denisovan groups. How is that even possible?

Model

The islands were a crossroads. People arrived, mixed with one Denisovan population, then later arrivals mixed with different Denisovan groups. It happened multiple times over thousands of years. The genetic record shows all three encounters.

Inventor

You mentioned the same gene showing up in Africa and Ecuador. Is that coincidence?

Model

Probably not. When different populations face similar environmental pressures—thin air in mountains, dense forests, unfamiliar diseases—they sometimes converge on the same genetic solutions. It's natural selection finding the same answer in different places.

Inventor

What happens next with this research?

Model

The immediate payoff is medical. If we understand which ancient DNA variants are active in which populations, we can improve genetic screening and treatment for communities that have been left out of research. But longer term, it changes how we think about evolution. We're not separate from our extinct cousins. We're still carrying their solutions to old problems.

Quer a matéria completa? Leia o original em Earth.com ↗
Fale Conosco FAQ